THE VALUE OF TOX AS A DIAGNOSTIC MARKER FOR MYCOSIS FUNGOIDES (MF)

Assessment of The Diagnostic Value of TOX Versus CD3 Immunohistochemical Markers in Detection of Early Mycosis Fungoides Cases

Mycosis Fungoides Diagnosis Using TOX Versus Old Panel Immunohistochemical Markers

Role of CD319 Expression as A Diagnostic and Prognostic Marker in Plasma Cell Myeloma Patients

Serum Soluble CD163 as a Marker of Activity in MS Patients

Evaluation of the molecular marker TOX protein in diagnosis of early stages of mycosis fungoides

Assessment of the serum and tissue levels of Endocan in Mycosis fungoides patients

Study the Role of Some Immune Markers in Patients Infected with Cutaneous Leishmaniasis

Role of toll-like receptor 6 in pathogenesis of mycosis fungoides

INTERLEUKIN 23 AND INTERLEUKIN17 IN PSORIASIS, ATOPIC DERMATITIS AND LICHEN PLANUS: A SEROLOGICAL STUDY